Image credit: Unsplash

Exciting breakthroughs in Alzheimer’s disease research have led to the development of a new drugs called donanemab…which has shown promising results in slowing the progression of the disease by up to 35% in early-stage patients.

The medical community is enthusiastic about these developments, and the findings offer hope for patients and families affected by the devastating condition.

(Visited 63 times, 1 visits today)
Download Audio

The Wire is produced in partnership by

Contributor Stations

Supporters and Program Distribution